BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30796496)

  • 1. Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer.
    Abo-Madyan Y; Welzel G; Sperk E; Neumaier C; Keller A; Clausen S; Schneider F; Ehmann M; Sütterlin M; Wenz F
    Strahlenther Onkol; 2019 Jul; 195(7):640-647. PubMed ID: 30796496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
    Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
    JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A.
    Sperk E; Welzel G; Keller A; Kraus-Tiefenbacher U; Gerhardt A; Sütterlin M; Wenz F
    Breast Cancer Res Treat; 2012 Aug; 135(1):253-60. PubMed ID: 22842984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
    Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
    Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of concervative breast surgery and intraoperative radiation therapy for early breast cancer: a single-center, open, non-randomized, prospective pilot study.
    Cedolini C; Bertozzi S; Seriau L; Londero AP; Concina S; Moretti E; Padovani R; Pasqualucci A; Ceschia T; Risaliti A
    Oncol Rep; 2014 Apr; 31(4):1539-46. PubMed ID: 24534891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Radiation Therapy (IORT): A Series of 1000 Tumors.
    Silverstein MJ; Epstein M; Kim B; Lin K; Khan S; Snyder L; Guerra L; Coleman C; Chen P
    Ann Surg Oncol; 2018 Oct; 25(10):2987-2993. PubMed ID: 29968030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative Radiation Using Low-Kilovoltage X-Rays for Early Breast Cancer: A Single Site Trial.
    Silverstein MJ; Epstein MS; Lin K; Chen P; Khan S; Snyder L; Guerra LE; De Leon C; Mackintosh R; Coleman C; Lopez J; Kim B
    Ann Surg Oncol; 2017 Oct; 24(10):3082-3087. PubMed ID: 28766211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option?
    Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA
    Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience.
    Fung MC; Schultz DJ; Solin LJ
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):959-67. PubMed ID: 9276360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.
    Mellon EA; Orman A; Joya LE; Montejo ME; Laronga C; Hoover SJ; Lee MC; Khakpour N; Kubal PF; Diaz R
    Brachytherapy; 2017; 16(1):174-180. PubMed ID: 27816540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study.
    Lemanski C; Bourgier C; Draghici R; Thezenas S; Morel A; Rouanet P; Colombo PE; Mourregot A; Delmond L; Fenoglietto P; Ailleres N; Azria D; Gutowski M
    Cancer Radiother; 2020 Apr; 24(2):114-119. PubMed ID: 32171675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
    Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
    Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR; Baum M; Joseph D
    Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.